1. Minn H, Kauhanen S, Seppanen M. Nuutila P.18F-FDOPA: a multiple-target molecule. J Nucl Med. 2009;50:1915–8.
2. Garnett ES, Firnau G, Nahmias C. Dopamine visualized in basal ganglia of living man. Nature. 1983;305:182–4.
3. Ibrahim N, Kusmirek J, Struck AF, Floberg JM, Perlman SB, Gallagher C, Hall LT. The sensitivity and specificity of F-DOPA PET in a movement disorder clinic. Am J Nucl Med Mol Imaging. 2016;6:102–9.
4. Stormezanda GN, Chavesa LT, Garcíaa DV, Doorduina J, De Jongb BM, Leendersb KL, Kremerb BPH, Dierckxa RAJO. Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders. Neuroimage Clin. 2020;25:102161.
5. Chen W, Silverman DHS, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T. 18F FDOPA PET Imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med. 2006;47:904–11.